Potassium Replacement in Pediatric Patients

Introduction to Potassium Replacement

The American Academy of Pediatrics recommends correcting hypomagnesemia before treating hypokalemia, as hypomagnesemia is a common cause of refractory hypokalemia 1, 2
Magnesium levels should be greater than 0.6 mmol/L before hypokalemia will respond to treatment 3
Organic magnesium salts (aspartate, citrate, lactate) should be used instead of oxide or hydroxide for better bioavailability 3

Medications (diuretics, corticosteroids, caffeine) are common causes of hypokalemia 1, 2
Gastrointestinal losses (diarrhea, vomiting) can also lead to hypokalemia 1, 2
Premature infants have increased demand due to immaturity 1, 2
Refeeding syndrome can occur when parenteral nutrition is initiated with high amino acids 1, 2

The standard dose is 1-2 mEq/kg/day divided into 2-4 doses 4
Pharmacological range: 5-10 mmol/kg/day for specific conditions such as Bartter syndrome 4
Potassium chloride is the preferred form over potassium sulfate 4
Administration should be with or immediately after food to reduce gastrointestinal irritation 4

Indications for intravenous treatment include K+ ≤2.5 mEq/L, electrocardiographic changes, severe neuromuscular symptoms, or non-functional gastrointestinal tract 3
Correction should be done slowly, with a maximum rate of 10 mEq/hour or 200 mEq in 24 hours 3
Concentration in IV fluids: 4-6 mEq per 100 mL 3
A calibrated infusion device should be used obligatorily 3

During the acute phase (first 24-48 hours), monitoring should include heart rate, respiratory rate, blood pressure, and neurological status every hour 5
Electrocardiographic monitoring should be continuous to evaluate T waves and evidence of hyper/hypokalemia 5
Glucose capillary measurements should be done every hour 5
Electrolytes, blood glucose, and arterial gases should be measured every 2-4 hours 5, 3

Premature infants and newborns: anticipate primary sodium depletion in premature infants <34 weeks due to deficient tubular reabsorption 1, 2
Potassium supply should be parallel to amino acid supply to avoid refeeding syndrome 1, 2
Non-oliguric hyperkalemia (NOHK) can develop early without potassium intake 1, 2
In diabetic ketoacidosis, add 20-30 mEq/L of potassium (2/3 KCl and 1/3 KPO4) to each liter of IV fluid once K+ falls <5.5 mEq/L with adequate urine output 3
If K+ <3.3 mEq/L, delay insulin therapy until potassium is restored to prevent potentially fatal arrhythmias 3

Never supplement potassium without checking and correcting magnesium first, as magnesium depletion causes dysfunction of potassium transport systems and increases renal excretion 3
Avoid administering potassium IV rapidly without cardiac monitoring, as rapid administration can cause cardiac arrhythmias and cardiac arrest 3
Avoid digoxin before correcting hypokalemia, as administering digoxin before correcting hypokalemia significantly increases the risk of potentially fatal arrhythmias 3

Target range for serum K+: 4.0-5.0 mEq/L, which minimizes the risk of cardiac complications 3
Both hypokalemia and hyperkalemia increase the risk of mortality 3
In specific conditions such as Bartter syndrome, a reasonable goal may be 3.0 mmol/L, and complete normalization may not be achievable in some patients 3, 4